证券代码：300044 证券简称：赛为智能 2019 年 07 月 19 日投资者关系活动记录表 编号：2019—004 | --- | --- | --- | |---------|------------|-----------------------------------------------------------------------------------| | | | | | 投资 | ■ | 特定对象调研 □分析师会议 | | 者关 | □ | 媒体采访 □业绩说明会 | | 系活 | □ | 新闻发布会 □路演活动 | | | ■ 现场参观 | | | 动类 别 | □其他 | | | 参与 | | 调研机构：深圳德威资本投资管理有限公司、深圳菁英时代基金管理股份有限公司、中 | | 单位 | | 信资本、厚生资产管理有限公司、上海通晟资产管理有限公司、深圳前海天德融汇资产管理 | | 名称 | | 有限公司、北京新湖巨源投资管理有限公司、深圳龙腾资产管理有限公司、深圳佳宇资本管 | | | | 理有限公司、深圳前海永谦资产管理有限公司、深圳市穂丰基金管理有限公司、深圳市小狼 | | ...

证券代码：300044 证券简称：赛为智能 2019 年 06 月 28 日投资者关系活动记录表 编号：2019—003 | --- | --- | --- | |-------|----------------|--------------------------------| | | | | | 投资 | ■ | 特定对象调研 □分析师会议 | | 者关 | □ | 媒体采访 □业绩说明会 | | 系活 | □ | 新闻发布会 □路演活动 | | 动类 | ■ 现场参观 | | | | □其他 | | | 别 | | | | 参与 | | | | 单位 | | | | 名称 | | | | 及人 | | 调研机构：华创证券、嘉禾资产 | | 员姓 | | | | 名 | | | | 时间 | 2019 年 06 | 月 28 日上午 09:30-11:30 | | --- | --- | |-------|------------------------------------------------------------------------------------| | 地点 | 深圳市南山区高新 ...

证券代码：300044 证券简称：赛为智能 2019 年 05 月 16 日投资者关系活动记录表 编号：2019—002 | --- | --- | --- | |---------|----------------|----------------------------------------------------------------------------------| | | | | | 投资 | ■ | 特定对象调研 □分析师会议 | | 者关 | □ | 媒体采访 □业绩说明会 | | 系活 | □ | 新闻发布会 □路演活动 | | | ■ 现场参观 | | | 动类 别 | □其他 | | | 参与 | | 调研机构：中信建投证券股份有限公司、深圳市小狼资产管理有限公司、广州磐云基金 | | 单位 | | 管理有限公司、深圳君宇通资本管理有限公司、深圳市川汇资产管理有限公司、深圳市瑞达 | | 名称 | | 资产管理有限公司、深圳兰度投资基金管理有限公司、深圳市贝富盛资产管理有限公司、君 | | | | 领天下投资管理（深圳）有限责任公司、深圳市前海登程资产管理有限公司、深圳市君如资 | ...

证券代码：300044 证券简称：赛为智能 深圳市赛为智能股份有限公司投资者关系活动记录表 编号：2019—001 | --- | --- | --- | |-------|------------------------|------------------------------------| | | | | | 投资 | ■ | 特定对象调研 □分析师会议 | | 者关 | □ 媒体采访 □业绩说明会 | | | 系活 | □新闻发布会 □路演活动 | | | | ■ 现场参观 | | | 动类 | □ 其他 | | | 别 | | | | 参与 | | | | 单位 | | | | 名称 | | | | 及人 | | 调研机构：高盛（亚洲）有限责任公司 | | 员姓 | | | | 名 | | | | 时间 | 2019 年 04 月 | 30 日下午 14:00-15:30 | | --- | --- | |-------|----------------------------------------------------------------------------------| | 地点 ...

证券代码：300044 证券简称：赛为智能 深圳市赛为智能股份有限公司投资者关系活动记录表 编号：2018—001 | --- | --- | --- | |-------|-----------------------|--------------------------| | | | | | 投资 | ■ | 特定对象调研 □分析师会议 | | 者关 | □ | 媒体采访 □业绩说明会 | | 系活 | □新闻发布会 □路演活动 | | | 动类 | ■ 现场参观 | | | | □ 其他 | | | 别 | | | | 参与 | | | | 单位 | | | | 名称 | | | | 及人 | 调研机构：国泰君安 | | | 员姓 | | | | 名 | | | | 时间 | 2018 年 5 月 | 11 日上午 9:30-11:30 | | --- | --- | |-------|----------------------------------------------------------------------------------------------------| | 地点 | 深 ...

Group 1: Company Overview and Development Strategy - The company focuses on four main sectors: smart cities, big data, artificial intelligence, and cultural education [2] - Future plans include establishing a leading research platform in artificial intelligence, big data, and smart city applications [2][3] - The company aims to expand its overseas market through the "Belt and Road" initiative and industry chain integration [3] Group 2: Research and Technological Capabilities - The company has seen a year-on-year increase in R&D investment, ensuring robust technological development [3] - Key technologies mastered include IoT, big data, cloud computing, and artificial intelligence [3] - Collaborations with industry experts and institutions like Huawei, Tencent, and Osaka University enhance the company's technological edge [3] Group 3: Future Development and Product Focus - The establishment of an artificial intelligence research institute aims to advance technologies in autonomous drones and smart healthcare products [4] - The company plans to integrate AI technology into various business sectors, fostering new technologies and market competitiveness [4] - Marketing efforts will focus on promoting intelligent terminal products in the healthcare sector, targeting hospitals and nursing homes [4] Group 4: Talent Acquisition and Retention - The company emphasizes a "people-oriented" culture, focusing on talent development as a strategic priority [4] - Measures include a comprehensive talent recruitment and development system, performance evaluation, and incentive mechanisms [4] - A second phase of the equity incentive plan has been implemented to stabilize and motivate core personnel [4] Group 5: Capital Market Utilization - The company plans to leverage capital markets to enhance its strength, including issuing convertible bonds and acquiring strategic companies [5] - Engaging with professional investment institutions will broaden financing channels and support strategic initiatives [5]

证券代码：300044 证券简称：赛为智能 深圳市赛为智能股份有限公司投资者关系活动记录表 编号：2018—003 | --- | --- | --- | |-------|-----------------------|--------------------------------| | | | | | 投资 | ■ | 特定对象调研 □分析师会议 | | 者关 | □ | 媒体采访 □业绩说明会 | | 系活 | □新闻发布会 □路演活动 | | | 动类 | ■ 现场参观 | | | | □ 其他 | | | 别 | | | | 参与 | | | | 单位 | | | | 名称 | | | | 及人 | 调研机构：中泰证券 | | | 员姓 | | | | 名 | | | | 时间 | 2018 年 10 | 月 31 日下午 15:30-17:30 | | --- | --- | |-----------|----------------------------------------------------------------------------------------------| | ...

证券代码：300044 证券简称：赛为智能 深圳市赛为智能股份有限公司投资者关系活动记录表 编号：2018—004 | --- | --- | --- | |-------|----------------|------------------------------------------------| | | | | | 投资 | ■ | 特定对象调研 □分析师会议 | | 者关 | ■ | 媒体采访 □业绩说明会 | | 系活 | | □新闻发布会 □路演活动 | | 动类 | ■ 现场参观 | | | | □ 其他 | | | 别 | | | | 参与 | | | | 单位 | | | | 名称 | | | | 及人 | | 调研机构：南山人寿（台湾）、深圳商报、华泰证券 | | 员姓 | | | | 名 | | | | 时间 | 2018 年 11 | 月 6 日下午 14:00-17:00 | | --- | --- | |-------|-------------------------------------------------------------------------------- ...

编号：2018—005 证券代码：300044 证券简称：赛为智能 深圳市赛为智能股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------|----------------|--------------------------------------------------------------------------------------| | | | | | 投资 | ■ | 特定对象调研 □分析师会议 | | 者关 | □ | 媒体采访 □业绩说明会 | | 系活 | | □新闻发布会 □路演活动 | | 动类 | ■ 现场参观 | | | | □ 其他 | | | 别 | | | | 参与 单位 | | 调研机构：方正证券、国泰君安证券、国信证券、恒泰证券、华泰证券、招商证券、海通 | | | | 证券、中泰证券、申万宏源证券、东证资管、瀚信资产、嘉合基金、普渡资本、康瑞资本、前海 | | 名称 | | 联鑫、鼎熙资本、前海人寿、上海智焓投资、鑫鼎基金、龙光金融、北京泽铭投资有限公司、深 | | 及人 | | 圳华顺世纪资产管理有限公司、深圳瑞华信投资有限 ...

Revenue and Profit - Revenue for Q3 2022 was ¥91,114,099.26, a decrease of 23.61% compared to the same period last year[4] - The company's operating revenue for the reporting period was approximately CNY 240.32 million, a decrease of 65.20% compared to the same period last year[10] - Total operating revenue for Q3 2022 was CNY 240,315,249.78, a decrease of 65.2% compared to CNY 690,547,147.70 in the same period last year[26] - Net profit attributable to shareholders was -¥12,995,390.43, a decline of 120.70% year-on-year[4] - Net loss for Q3 2022 was CNY 33,657,900.12, compared to a net profit of CNY 10,341,178.38 in Q3 2021[27] - The total comprehensive loss for Q3 2022 was CNY 33,714,041.44, compared to a comprehensive income of CNY 10,512,055.67 in Q3 2021[28] Cash Flow - Cash flow from operating activities for the year-to-date reached ¥85,809,679.89, an increase of 886.02%[4] - The net cash flow from operating activities increased by 886.02% year-on-year to approximately CNY 85.81 million, mainly due to a reduction in cash payments for goods and services[10] - The net cash flow from operating activities for Q3 2022 was ¥85,809,679.89, a significant improvement compared to a negative cash flow of ¥10,916,972.21 in Q3 2021[31] - Cash flow from operating activities for Q3 2022 was CNY 354,305,871.29, compared to CNY 417,922,066.94 in the previous period[30] - The net cash flow from investment activities decreased by 29.53% year-on-year to approximately CNY 106.49 million, attributed to lower cash received from subsidiary disposals[11] - The net cash flow from financing activities decreased by 139.63% year-on-year to approximately CNY -276.39 million, primarily due to a reduction in cash received from borrowings[11] Assets and Liabilities - Total assets decreased by 35.01% to ¥2,157,889,572.22 compared to the end of the previous year[5] - As of September 30, 2022, total assets decreased to CNY 2,157,889,572.22 from CNY 3,320,157,641.13 at the beginning of the year, representing a decline of approximately 35%[21] - The company's total liabilities decreased to CNY 1,154,488,173.34 from CNY 2,283,042,200.81 year-on-year, a reduction of 49.3%[25] - Total current liabilities decreased to CNY 45,092,213.34 from CNY 324,416,995.76, a decline of about 86%[23] - The company's total liabilities included a significant increase in lease liabilities, which rose by 2547.86% to approximately CNY 4.45 million due to the renewal of certain lease contracts[10] Investments and Expenditures - Long-term equity investments dropped by 100% to ¥0 due to the sale of equity in Anhui Haida[9] - Development expenditures increased by 120.85% to ¥39,848,999.69, reflecting higher capitalized R&D investments[9] - Research and development expenses for Q3 2022 were CNY 36,898,154.22, a decrease of 27.5% from CNY 50,942,435.91 in the same period last year[26] - Investment income plummeted by 98.85% year-on-year to approximately CNY 1.11 million, also related to the previous year's sale of a subsidiary[10] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 56,084[13] - The total equity attributable to shareholders of the parent company was CNY 1,004,164,557.63, down from CNY 1,034,382,776.55 year-on-year[25] - The company reported a total of 100,891,414 restricted shares at the end of the period, with 70,675 shares released during the quarter[17] Legal and Other Matters - The company has ongoing litigation and has disclosed several announcements regarding significant legal matters throughout the quarter[18] - The company experienced a significant increase in credit impairment losses, amounting to CNY 40,267,202.27, compared to a reversal of CNY 23,103,987.95 in the previous year[27] - The company reported a credit impairment loss of approximately CNY 40.27 million, an increase of 274.29% year-on-year, primarily due to the reversal of provisions for receivables[10] Cash and Cash Equivalents - The company reported a significant reduction in cash and cash equivalents, down 55.86% to ¥70,876,208.66, mainly due to loan repayments[9] - Cash and cash equivalents dropped significantly to CNY 70,876,208.66 from CNY 160,574,215.48, a decrease of about 56%[22] - The total cash and cash equivalents at the end of Q3 2022 stood at ¥61,158,687.30, down from ¥143,477,492.35 at the end of Q3 2021[32]